Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder

NCT00252343 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
360
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi